WEDNESDAY, Aug. 20, 2025 (HealthDay News) -- In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the
Stapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps

34